ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
0,121
-0,0069
(-5,39%)
Geschlossen 29 März 9:00PM
0,1279
0,0069
(5,70%)
Nach Börsenschluss: 12:34AM
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,1279
Gebot
-
Fragen
-
Volumen
414.706
0,1201 Tagesbereich 0,1304
0,1105 52-Wochen-Bereich 0,62
Marktkapitalisierung
Handelsende
0,1279
Handelsbeginn
0,1304
Letzte Trade
1357
@
0.121
Letzter Handelszeitpunkt
Finanzvolumen
US$ 50.700
VWAP
0,122256
Durchschnittliches Volumen (3 Mio.)
1.029.752
Ausgegebene Aktien
63.706.446
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,96
Gewinn pro Aktie (EPS)
-0,45
Erlöse
202k
Nettogewinn
-28,96M

Über AIM ImmunoTech Inc

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
AIM ImmunoTech Inc is listed in the Biological Pds,ex Diagnstics sector of the Amerikanische Börse with ticker AIM. The last closing price for AIM ImmunoTech was US$0,13. Over the last year, AIM ImmunoTech shares have traded in a share price range of US$ 0,1105 to US$ 0,62.

AIM ImmunoTech currently has 63.706.446 shares in issue. The market capitalisation of AIM ImmunoTech is US$8,15 million. AIM ImmunoTech has a price to earnings ratio (PE ratio) of -3.96.

AIM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0036-2.737642585550.13150.1420.12022863600.13574154CS
40.00292.320.1250.1420.11275410420.12704989CS
12-0.0941-42.38738738740.2220.2540.110510297520.15661403CS
26-0.1521-54.32142857140.280.2890.11057256120.17935819CS
52-0.3401-72.67094017090.4680.620.11054993740.23842187CS
156-1.0021-88.68141592921.131.380.11052964720.45410025CS
260-2.1421-94.36563876652.274.30.110510074552.1386502CS

AIM - Frequently Asked Questions (FAQ)

What is the current AIM ImmunoTech share price?
The current share price of AIM ImmunoTech is US$ 0,1279
How many AIM ImmunoTech shares are in issue?
AIM ImmunoTech has 63.706.446 shares in issue
What is the market cap of AIM ImmunoTech?
The market capitalisation of AIM ImmunoTech is USD 8,15M
What is the 1 year trading range for AIM ImmunoTech share price?
AIM ImmunoTech has traded in the range of US$ 0,1105 to US$ 0,62 during the past year
What is the PE ratio of AIM ImmunoTech?
The price to earnings ratio of AIM ImmunoTech is -3,96
What is the cash to sales ratio of AIM ImmunoTech?
The cash to sales ratio of AIM ImmunoTech is 562,5
What is the reporting currency for AIM ImmunoTech?
AIM ImmunoTech reports financial results in USD
What is the latest annual turnover for AIM ImmunoTech?
The latest annual turnover of AIM ImmunoTech is USD 202k
What is the latest annual profit for AIM ImmunoTech?
The latest annual profit of AIM ImmunoTech is USD -28,96M
What is the registered address of AIM ImmunoTech?
The registered address for AIM ImmunoTech is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AIM ImmunoTech website address?
The website address for AIM ImmunoTech is www.aimimmuno.com
Which industry sector does AIM ImmunoTech operate in?
AIM ImmunoTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 13,94
(21,32%)
30,41M
UVIX2x Long VIX Futures ETF
US$ 37,36
(17,23%)
7,41M
ETHDProshares Ultrashort Ether ETF
US$ 51,75
(13,26%)
166,88k
UVXYProShares Ultra VIX Short Term Futures ETF
US$ 23,54
(13,06%)
34,68M
ETQT Rex 2X Inverse Ether Daily Target ETF
US$ 20,90
(12,80%)
2,63k
SBEVSplash Beverage Group Inc
US$ 1,545
(-44,82%)
261,39k
IBOImpact Biomedical Inc
US$ 1,595
(-30,04%)
832,19k
AXILAXIL Brands Inc
US$ 5,415
(-22,20%)
22,22k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 5,52
(-21,70%)
87,94M
PLAGPlanet Green Holdings Corp
US$ 1,02
(-16,39%)
67,91k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 16,03
(-9,74%)
138,23M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 5,52
(-21,70%)
87,94M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 4,065
(7,26%)
81,5M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 7,25
(6,30%)
81,15M
SPYSPDR S&P 500
US$ 555,66
(-2,01%)
71,66M

AIM Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen